ZNTL : Insider Transactions for Zentalis Pharmaceuticals, Llc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Zentalis Pharmaceuticals, Llc (ZNTL)

$0.00 0.00 (0.00%) as of 4:30 Tue 11/30

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

84,924,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$ - $

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	22,000	22,000
Total Buy Value	$0	$0	$219,391	$219,391
Total People Bought	0	0	2	2
Total Buy Transactions	0	0	2	2
Total Shares Sold	12,953	41,815	68,993	346,626
Total Sell Value	$157,325	$490,017	$1,047,834	$8,137,870
Total People Sold	2	5	8	8
Total Sell Transactions	2	8	12	35
End Date	2024-04-07	2024-01-05	2023-07-07	2022-07-07

Adjust Filter Settings

Records found: 243

Page 8 of 10

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Bunker Kevin D.

Chief Operating Officer

• – –

2021-04-13

4

AS

$45.00

$171,450

I/I

(3,810)

50,520

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-03-10

4

AS

$45.24

$213,542

I/I

(4,720)

58,940

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-03-03

4

AS

$45.07

$166,747

I/I

(3,700)

63,660

-

Epperly Melissa B,

Chief Financial Officer

• – –

2021-03-01

4

AS

$41.67

$128,482

D/D

(3,083)

283,430

-

Director

– • –

2021-03-01

4

AS

$41.69

$416,858

D/D

(10,000)

563,942

-

President & CEO

• • –

2021-03-01

4

AS

$41.13

$1,117,225

D/D

(26,794)

1,767,373

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-03-01

4

AS

$41.65

$175,352

I/I

(4,210)

67,360

-

Director

– • –

2021-02-11

4

A

$0.00

$0

D/D

13,750

573,942

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-02-11

4

A

$0.00

$0

D/D

18,750

1,044,464

-

Voliotis Dimitris

SVP, Clinical Development

• – –

2021-02-11

4

A

$0.00

$0

D/D

6,250

6,250

-

President & CEO

• • –

2021-02-11

4

A

$0.00

$0

D/D

43,750

1,794,167

-

Epperly Melissa B,

Chief Financial Officer

• – –

2021-02-11

4

A

$0.00

$0

D/D

15,000

286,513

-

Chief Legal Officer

• – –

2021-02-11

4

A

$0.00

$0

D/D

6,250

6,250

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-02-01

4

AS

$37.29

$157,918

I/I

(4,210)

71,570

-

Director

– • –

2021-02-01

4

AS

$37.38

$374,865

D/D

(10,000)

560,192

-

President & CEO

• • –

2021-02-01

4

AS

$37.23

$1,004,837

D/D

(26,794)

1,750,417

-

Epperly Melissa B,

Chief Financial Officer

• – –

2021-02-01

4

AS

$37.45

$115,805

D/D

(3,083)

271,513

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-01-04

4

AS

$50.40

$437,559

I/I

(8,420)

75,780

-

Bunker Kevin D.

Chief Operating Officer

• – –

2021-01-04

4

AS

$50.39

$1,383,558

D/D

(26,567)

1,025,713

-

Epperly Melissa B,

Chief Financial Officer

• – –

2021-01-04

4

AS

$50.36

$160,034

D/D

(3,083)

274,596

-

President & CEO

• • –

2021-01-04

4

AS

$50.47

$1,394,907

D/D

(26,794)

1,777,211

-

Director

– • –

2021-01-04

4

AS

$50.41

$519,323

D/D

(10,000)

570,192

-

Bunker Kevin D.

Chief Operating Officer

• – –

2020-12-24

4

GD

$0.00

$0

D/D

1,600

1,052,280

-

Director

– • –

2020-12-24

4

AS

$0.00

$0

I/I

(18,473)

0

-

Director

– • –

2020-12-08

4

AS

$54.19

$1,281,056

D/D

(22,573)

580,192

-

243 Records found	1 2 3 4 5 6 7 8 9 Next	Page 8 of 10

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.